FDA Brief

Warning letters Biologics

FDA warning letter to

Cellebration LLC

Issued Sep 12, 2025Posted Sep 23, 2025Center for Biologics Evaluation and Research (CBER)

Deviations/CFR/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps). We haven't summarized this letter yet. Read it on fda.gov.